期刊文献+

以IIFAR为基础的信息支持对神经母细胞瘤患儿家属疾病不确定感、心理弹性及正念水平的影响 被引量:2

Influence of IIFAR-based information support on illness uncertainty, resilience and mindfulness in family members of children with neuroblastoma
原文传递
导出
摘要 目的 探讨以IIFAR为基础的信息支持对神经母细胞瘤患儿家属疾病不确定感、心理弹性及正念水平的影响。方法 将2020年1月至2020年10月南京医科大学附属儿童医院收治的54例神经母细胞瘤患儿的家属纳入对照组,2020年11月至2021年8月收治的54例神经母细胞瘤患儿的家属纳入观察组。对照组给予常规的健康教育,观察组给予以IIFAR为基础的信息支持方案。采用疾病不确定感父母量表(PPUS)评估患儿家属的疾病不确定感,心理弹性量表(CD-RISC)评估患儿家属的心理弹性,正念注意觉知量表(MAAS)评估患儿家属的正念水平。比较两组患儿家属疾病不确定感、心理弹性、正念水平以及健康教育满意度。结果 干预后,对照组和观察组患儿家属的疾病不确定感各项评分均降低,且与对照组相比,观察组疾病不确定感更低(P<0.05)。干预后,两组患儿家属的坚韧性、力量、乐观性评分均升高,且与对照组相比,观察组家属的坚韧性、力量、乐观性评分更高(P<0.05)。两组患儿家属干预后的MAAS评分均升高,且与对照组相比,观察组MAAS评分更高(P<0.05)。对照组患儿家属健康教育满意度明显低于观察组(79.63%vs 96.30%)(χ^(2)=7.083,P=0.008)。结论 对神经母细胞瘤患儿家属实施以IIFAR为基础的信息支持能够有效降低患儿家属的疾病不确定感,提高心理弹性及正念水平,且患儿家属健康教育满意度高,有临床推广价值。 Objective To investigate the effect of IIFAR-based information support on illness uncertainty, resilience and mindfulness in family members of children with neuroblastoma. Methods The family members of 54 children with neuroblastoma treated in our hospital from January 2020 to October 2020 were included in the control group, and the family members of 54 children with neuroblastoma treated in our hospital from November 2020 to August 2021 family members were included in the observation group. The control group was given routine health education, and the observation group was given an IIFAR-based information support program. The parents’ perception of uncertainty about illness(PPUS) was used to evaluate the uncertainty of illness in children’s family members, the resilience scale(CD-RISC) used to evaluate the psychological resilience of children’s family members, and the mindfulness-attention awareness scale(MAAS) was used to evaluate the level of mindfulness of family members. The uncertainty of illness, psychological resilience, mindfulness level and health education satisfaction of family members of the two groups were compared. Results After intervention, the scores of illness uncertainty in the family members of the children in the control group and the observation group were decreased, and the scores of illness uncertainty in observation group were lower compared with control group(P<0.05). After intervention,the scores of toughness, strength and optimism of the families of the children in the two groups were increased, and the scores of toughness, strength and optimism of the family members of the observation group were higher compared with control group(P<0.05). The MAAS scores of the families of the children in the two groups were increased after intervention, and the MAAS scores of the observation group were higher compared with control group(P<0.05). The health education satisfaction of the children in the control group was lower compared with observation group(79.63% vs 96.30%)(χ^(2)=7.083, P=0.008).Conclusion Implementing IIFAR-based information support for the families of children with neuroblastoma can effectively reduce the uncertainty of the disease, improve the level of psychological resilience and mindfulness, and have high satisfaction with health education, which has clinical promotion value.
作者 郭培培 陈川丽 GUO Peipei;CHEN Chuanli(Children’s Hospital of Nanjing Medical University,Nanjing,Jiangsu 210008,China)
出处 《中国优生与遗传杂志》 2022年第7期1257-1261,共5页 Chinese Journal of Birth Health & Heredity
基金 中国博士后基金面上项目(2020M671550)。
关键词 IIFAR 信息支持 神经母细胞瘤 不确定感 心理弹性 IIFAR information support neuroblastoma uncertainty resilience
  • 相关文献

参考文献14

二级参考文献143

  • 1陆敏,鲍丽超.基于微信平台的延续性护理措施对促进直肠癌造口术患者康复的效果观察[J].中华肿瘤防治杂志,2019,26(S01):217-217. 被引量:11
  • 2王才康,胡中锋,刘勇.一般自我效能感量表的信度和效度研究[J].应用心理学,2001,7(1):37-40. 被引量:2613
  • 3万崇华,陈明清,张灿珍,汤学良,孟琼,张晓磬.癌症患者生命质量测定量表EORTC QLQ-C30中文版评介[J].实用肿瘤杂志,2005,20(4):353-355. 被引量:1270
  • 4Howlader N, Noone AM, Krapcho M, et al, eds. SEER statistics review, 1975-2009 ( Vintage 2009 Populations)[M]. Bethesda, Md: National Cancer Institute, 2012.
  • 5Homer M J, Ries LA, Krapcho M, et al. SEER cancer statistics review, 1975-2006[M]. Bethesda, Md: National Cancer Institute, 2009.
  • 6Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, andresponse to treatment[J]. J Clin Oncol, 1993, 11 (8): 1466- 1477.
  • 7Shimada H,Ambros IM, Dehner LP, et al. The Ivtemational Neuroblastoma Pathology Classification (the Shimada system) [J]. Cancer,1999,86 (2) : 364-372.
  • 8Peuchmaur M Amore ES, Joshi VV, et al. Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular [J ]. Cancer, 2003, 98 (10) : 2274-2281.
  • 9Monclair T, Brodeur GM, Ambros PF, et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report [J]. J Clin Oncol , 2009, 27 (2): 298-303.
  • 10Brisse HJ,McCarville MB, Granata C, et al. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project[D]. Radiology, 2011, 261 (1) : 243-257.

共引文献284

同被引文献35

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部